Search
forLearn
5 / 801 resultslearn Beclomethasone
learn lycopene
learn Clascoterone
a novel topical treatment that inhibits DHT on androgen receptors
learn Black Cohosh
Research
5 / 320 results
research Climacteric Commentaries
Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.
research Skin climacteric aging and hormone replacement therapy
HRT helps improve skin issues caused by menopause.
research O conhecimento das mulheres de 40 a 65 anos de idade, residentes em Recife/PE ou em sua Região Metropolitana, sobre o climatério
Many women in Recife lack understanding of the climacteric period, needing better education and care.
research Impact of the new corona virus (SARS-CoV-2) pandemic on climateric women’s health: websurvey
The pandemic worsened mental health and healthcare access for middle-aged women, leading to negative changes in their lifestyle.
research Book review
The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.
Community Join
5 / 1000+ resultscommunity Hate how younger generation makes hair seem more important than it is
A 25-year-old man is worried about his girlfriend noticing his balding and is frustrated by society's focus on looks. He uses minoxidil, finasteride, and dutasteride for hair loss and considers being honest with her.
community Clascoterone 12 months phase 3 result out
Clascoterone is promising for hair loss, showing 24.5% improvement in satisfaction compared to placebo. Users consider it an alternative to finasteride, with concerns about absorption and side effects.
community European release of clascoterone
Clascoterone's European release is expected in Q4 2026, with FDA approval anticipated by mid-2027. The discussion includes questions about the approval timeline and potential acceleration due to unmet needs.
community Clascoterone full results in July
Clascoterone's full trial results are expected by mid-July 2026, but skepticism exists about timely release. Clascoterone is available at 5% from some telehealth companies.
community Taking part in a Clascoterone Study
The conversation is about a person considering participating in a study for Clascoterone, a topical cream for hair loss, and seeking advice on potential side effects. They have mild hair loss and are not currently using other treatments like finasteride.